Brachytherapy

Aetna covers brachytherapy for select cancers — specifically breast (e.g., MammoSite), esophageal, certain eye tumors (small choroidal melanoma and retinoblastomas <15 mm diameter and <8 mm thickness), and genitourinary cancers other than bladder (including prostate, penile, urethral). Electronic brachytherapy (e.g., AccuBoost, Xoft Axxent eBx), endovascular/intravascular brachytherapy, brachytherapy for many other indications (e.g., bladder, bone mets, brain, hematologic cancers, pancreatic, spinal tumors, keloids, AMD-related CNV) and CPTs 0394T/0395T are considered experimental/investigational and not covered; medical necessity decisions follow eviCore Radiation Therapy Clinical Guidelines and the combination ProstRcision approach for prostate has not demonstrated superiority.

"Eye tumors (e."

Sign up to see full coverage criteria, indications, and limitations.